2016 -
2017 Head of Development, CV and Metabolic Diseases @
2013 -
now Head, External R and D Innovation; Cardiovascular and Metabolic Disease Research Unit @
2000 -
2013 VP Clinical Development @
1995 -
2013 Assistant Physician @
1991 -
2004 Clinician @
1998 -
2000 Clinical Pharmacology @
Barry Ticho Education
Harvard Medical School
(Pediatric Cardiology)
Haverford College
BA (Biology)
University of Chicago - The Pritzker School of Medicine
Northwestern University - The Feinberg School of Medicine
(Pediatrics Residency Program)
Barry Ticho Skills
Research
Biologics
Clinical Development
Cardiology
Clinical Pharmacology
Autoimmune
Healthcare
Neurology
Customer Service
Neuroscience
Clinical Research
Biotechnology
Drug Discovery
Hospitals
Therapeutic Areas
Microsoft Excel
Cardiovascular
Immunology
Strategy
Development
Oncology
Translational Medicine
Barry Ticho Summary
Barry Ticho, based in Cambridge, MA, US, is currently a Chief Medical Officer at Stoke Therapeutics. Barry Ticho brings experience from previous roles at HAYA Therapeutics, Sania Therapeutics, Verve Therapeutics (acquired by Eli Lilly) and Cardior Pharmaceuticals (acquired by Novo Nordisk). Barry Ticho holds a Harvard Medical School. With a robust skill set that includes Research, Biologics, Clinical Development, Cardiology, Clinical Pharmacology and more. Barry Ticho has 4 emails and 2 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.